August 02, 2014 3:28 AM ET

Pharmaceuticals

Company Overview of Rivanna Pharmaceuticals Inc.

Company Overview

Rivanna Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel small molecule therapeutics for the treatment of neurological diseases and cancer. It develops therapeutics for prostate cancer, colon cancer, lymphoma, leukemia, epilepsy, and pain. The company was founded in 2004 and is based in Charlottesville, Virginia.

325 Barracks Hill

Charlottesville, VA 22901

United States

Founded in 2004

Phone:

434-973-0177

Key Executives for Rivanna Pharmaceuticals Inc.

Chairman and Interim Chief Executive Officer
Co-Founder
Age: 60
Founder and Vice President of Business Development
Co-Founder and Chief Operating Officer
Co-Founder
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Innovative Custom Products, Inc. United States
Intellikine, Inc. United States
P. J. Noyes Company, Inc. United States
Shire Regenerative Medicine, Inc. United States
CVI Pharmaceuticals Ltd. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Rivanna Pharmaceuticals Inc., please visit www.rivannapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.